Apelin elevates blood pressure in ICR mice with L-NAME-induced endothelial dysfunction
Open Access
- 15 March 2013
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 7 (5) , 1371-1375
Abstract
Apelin is the endogenous ligand of APJ, which belongs to the family of G protein‑coupled receptors. Apelin and APJ are highly expressed in various cardiovascular tissues, including the heart, kidney and vascular endothelial and smooth muscle cells. Although apelin exerts hypotensive effects via activation of endothelial nitric oxide synthase (eNOS), the ability of apelin to regulate blood pressure under pathological conditions is poorly understood. In the current study, NG‑nitro‑L‑arginine methyl ester (L‑NAME), a potent NOS inhibitor, was administered chronically, to induce peripheral vascular damage in mice. L‑NAME‑treated mice exhibited hypertension, increased vascular cell adhesion molecule‑1 and plasminogen activator inhibitor‑1 mRNA levels in the aorta and impaired vasodilatation associated with decreased aortic eNOS expression, consistent with endothelial damage. Three days following withdrawal of L‑NAME treatment, the blood pressure response to apelin stimulation was assessed. Although apelin reduced blood pressure in non‑treated mice, it was found to transiently elevate blood pressure in L‑NAME‑treated mice. These results indicate that apelin functions as a vasopressor peptide under pathological conditions, including vascular endothelial dysfunction in mice.Keywords
This publication has 19 references indexed in Scilit:
- Apelin-13 passes through the ADMA-damaged endothelial barrier and acts on vascular smooth muscle cellsPeptides, 2011
- Apelin Stimulates Myosin Light Chain Phosphorylation in Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cellsRegulatory Peptides, 2005
- Regulatory Roles for APJ, a Seven-transmembrane Receptor Related to Angiotensin-type 1 Receptor in Blood Pressure in VivoJournal of Biological Chemistry, 2004
- Long-Term Treatment With
N
ω
-Nitro- l -Arginine Methyl Ester Causes Arteriosclerotic Coronary Lesions in Endothelial Nitric Oxide Synthase-Deficient MiceCirculation, 2002
- Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in l-NAME-treated ratsEuropean Journal of Pharmacology, 2002
- [125I]‐(Pyr1)Apelin‐13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in manBritish Journal of Pharmacology, 2001
- Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ ReceptorBiochemical and Biophysical Research Communications, 1998
- The Role of Endothelium in Cardiovascular Homeostasis and DiseasesJournal of Cardiovascular Pharmacology, 1993
- Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage.Journal of Clinical Investigation, 1992